The Global AMR R&D Hub is currently:
- planning, designing, and building an online Dynamic Dashboard that will present all AMR R&D investments from the public and private sectors globally across the One Health continuum and is as close to real time as possible
- consulting with a Stakeholder Group, consisting of approximately 20 members from non-government organisations/civil society, industry, international research funding initiatives and academia, to advice the Hub on specific topics, including the Dynamic Dashboard
- working with the Market Analysis EAG that comprises of 15 members and two ex-officio members to evaluate and determine the market potential of interventions addressing priority antimicrobial resistant pathogens and indications, and
- consulting widely with experts, other initiatives and organisations to promote the work of the Global AMR R&D Hub and also ensure there is no duplication of effort.